Synthesis and PPAR-γ ligand-binding activity of the new series of 2′-hydroxychalcone and thiazolidinedione derivatives

Chemical and Pharmaceutical Bulletin

Volumn 54, Issue 3, 2006, Pages 368-371

  Sang, Hoon Jung ^a   Soo, Young Park ^b   Kim Pak, Youngmi ^b   Hong, Kyu Lee ^c   Kyong, Soo Park ^c   Kuk, Hyun Shin ^c   Ohuchi, Kazuo ^d   Shin, Hyun Kyung ^e   Sam, Rok Keum ^f   Soon, Sung Lim ^e  

^a Korea Institute of Science and Technology   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d TOHOKU UNIVERSITY   (Japan)

^e Hallym University   (South Korea)

^f Korea University   (South Korea)

Author keywords

2 ,5 dihydroxy 4 methoxychalcone; Chalconyl thiazolidinedione; PPAR

Indexed keywords

2' HYDROXY 4 METHOXY 4',5' DIMETHYLCHALCONE; 2' HYDROXY 4 METHOXY 5' METHYLCHALCONE; 2' HYDROXY 4 METHOXYCHALCONE; 2' HYDROXY 4,5' DIMETHOXYCHALCONE; 2' HYDROXYCHALCONE; 2',4' DIHYDROXY 4 METHOXYCHALCONE; 2',4'DIHYDROXY 4 METHYLCHALCONE; 2',5' DIHYDROXY 4 METHOXYCHALCONE; 2,2',4,4' TETRAHYDROXYCHALCONE; 2,3',4,4' TETRAHYDROXYCHALCONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 4,2',5' TRIHYDROXYCHALCONE; 5' BROMO 2' HYDROXY 4 METHOXYCHALCONE; 5' CHLORO 2' HYDROXY 4 DIMETHYLAMINOCHALCONE; 5' CHLORO 2' HYDROXY 4 METHOXYCHALCONE; 5' CHLORO 2',3 DIHYDROXYCHALCONE; CHALCONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

CHALCONE; CHALCONES; INDICATORS AND REAGENTS; LIGANDS; LUCIFERASES; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLIUM SALTS; THIAZOLES; THIAZOLIDINEDIONES; TRANSFECTION;

EID: 33645217958     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.54.368     Document Type: Article

References (23)

1. Mukherjee R., Drug News Perspect, 15, 261-267 (2002).
2. Kaplan F., Al-Majali K., Betteridge D. J., J. Cardiovasc. Risk, 8, 211-217 (2001).
3. Moller D. E., Nature (London), 414, 821-827 (2001).
4. Okuno A., J. Clin. Invest., 101, 1354-1361 (1998).
5. Bozdag O., Verspohl E. J., Ertan R., Arch. Pharm. (Weinheim), 332, 435-438 (1999).
6. Bozdag O., Verspohl E. J., Ertan R., Arzneim.-Forsch., 50, 539-543 (2000).
7. Dimmock J. R., Elias D. W., Beazely M. A., Kandepu N. M., Curr. Med. Chem., 6, 1125-1149 (1999).
8. Lim S. S., Jung S. H., Ji J., Shin K. H., Keum S. R., J. Pharm. Pharmacol., 53, 653-668 (2001).
9. Lim S. S., Jung S. H., Ji J., Shin K. H., Keum S. R., Chem. Pharm. Bull., 48, 1786-1789 (2000).
10. Winget G. D., Izawa S., Good N. E., Biochemistry, 8, 2067-2074 (1969).
11. Albuquerque J. F., Pharmazie, 50, 387-389 (1995).
12. Kamei R., Kadokura M., Kitagawa Y., Hazeki O., Oikawa S., Life Sci., 73, 2091-2099 (2003).
13. De Meyer N., Haemers A., Mishra L., Pandey H. K., Pieters L. A., Vanden Berghe D. A., Vlietinck A. J., J. Med. Chem., 34, 736-746 (1991).
14. Thakkar K., Cushman M., J. Org. Chem., 60, 6499-6510 (1995).
15. Vyas G. N., Shah N. M., Curr. Sci., 19, 318-319 (1950).
16. Mahanthy P., Panda S. P., Sabata B. K., Rout M. K., Ravenshaw C., Ind. J. Chem., 3, 121-123 (1965).
17. Reyes-Chilpa R., Gomez-Garibay F., Moreno-Torres G., Jimenez-Estrada M., Quiroz-Vasquez R. I., Holzforschung, 52, 459-462 (1998).
18. Shinoda J., Yakugaku Zasshi, 49, 214-220 (1928).
19. Lin C. N., Lee T. H., Hsu M. F., Wang J. P., Ko F. N., Teng C. M., J. Pharm. Pharmacol., 49, 530-536 (1997).
20. Hano Y., Suzuki S., Nomura T., Ueda S., Heterocycles, 29, 807-813 (1989).
21. Hsieh H. K., Tsao L. T., Wang J. P., Lin C. N., J. Pharm. Pharmacol., 52, 163-171 (2000).
22. Koos M., Repas M., Ciha M., Zvakova A., Chemicke Zvesti, 38, 231-237 (1984).
23. Nagy L., Tontonoz P., Alvarez J. G., Chen H., Evans R. M., Cell, 93, 229-240 (1998).